Salivary function in patients with reflux esophagitis: Effect of cisapride

Journal of Nuclear Medicine

Volumn 39, Issue 8 SUPPL., 1998, Pages 1449-1452

  Chen, Shy Den ^a   Kao, Chia Hung ^a   Chang, Chi Sen ^a   Chen, Gran Hum ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cisapride; Reflux esophagitis; Salivary function; Scintigraphy

Indexed keywords

BUFFER; CISAPRIDE; PERTECHNETIC ACID TC 99M;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND; POSTPRANDIAL STATE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SALIVARY GLAND; SALIVARY GLAND SCINTISCANNING; SALIVATION; SCINTILLATION CAMERA; SUBMANDIBULAR GLAND;

CISAPRIDE; ESOPHAGITIS, PEPTIC; FASTING; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; PIPERIDINES; POSTPRANDIAL PERIOD; RADIOPHARMACEUTICALS; SALIVARY GLANDS; SALIVATION; SODIUM PERTECHNETATE TC 99M;

EID: 0031830174     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Helm JF, Dodds WJ. Riedel DR, Teetcr BC, Hogan WJ. Arndorfer RC. Déterminants of esophageal acid clearance in normal subjects. Gastroenterologe- 1983:85:607-612.
2. Helm JF, Dodds WJ. Pelc LR. et al. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. A' Engl J Med 1984:310:284-288.
3. Helm JF, Dodds WJ, Hogan WJ. Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis. Gustroenterolo 1987:93:1393 1397.
4. Toussaint J, Gossuin A, Deruyttere M, Huhle F, Devis G. Healing and prevention of relapse of reflux oesophagitis by cisapride. Gut 1991:32:1280-1285.
5. Baldi F, Bianchi PG, Dobrilla G, et al. Cisapride versus placebo in reflux esophagitis. J Clin Gastroenterol 1988; 10:614-618.
6. Galmiche JP, Brandstatter G. Evreux M, et al. Combined therapy with cisapride and cimctidine in severe reflux oesophagitis: a double blind controlled trial GUI 1988:29: 675-681.
7. Blum AL, Adami B. Bouzo MH, et al. Effect of cisapride on relapse of esophagitis: a multinational, placebo-controlled trial in patients healed with an antisecretory drug. Dig Dis Sei 1993:38:551-560.
8. Holloway RH. Downton J, Mittchell B, Dent J. Effect of cisapride on postprandial gastroesophageal reflux. Gut I989;3():l 187-1193.
9. Schall GE, Andcrson EG, Wolf RO. et al. Xerostomia in Sjögren's syndrome Evaluation by sequential salivary scintigraphy. JAMA 1971:216:2109-2116.
10. Pilbrow WJ, Brownless SM, Cawood Jl. Dynes A. Hughes .ID, Stockdalc HR. Salivary scintigraphy, a suitable substitute for sialography. Br .1 Radiol 1990:63:190-196.
11. Sugihara T, Yoshimura Y. Scintigraphic evaluation of the salivary glands in patients with Sjögren's syndrome. Int J Oral Maxrllofac Surg 1988:17:71 75.
12. Daniels TE, Powell MR. Sylvester RA, Talal N. An evaluation of salivary scintigraphj in Sjögren's syndrome. Arthritis Rheum 1979;22:809-814.
13. Katz WA, Ehrlich GE, Gupta VP, Shapiro B. Salivary gland dysfunction in systemic lupus erythematous and rheumatoid arthritis. Arch Intern Mal 1980:140:949-951.
14. Valdes Olmos RA, Keus RB, Takes RP, et al. Seintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands. Cancer 1994;73:2886-2893.
15. Kohn WG, Ship JA, Patton EE, Fox PC. Salivary gland l;g'Tc-scintigraphy: a grading scale and correlation with major salivary gland flow rates. J Oral Pathol Mcil 1992:21:70-74.
16. Patel RS, Soffer E. Effects of cisapride on salivary production in normal subjects. Dig Dis Sei 1996:41:480-484.
17. Saroseik J, McCallum RW. What role do salivary inorganic components play in health and disease of the esophageal mucosa? Digestion 1995;56(suppl 10):24-3I.
18. Saroseik J, McCallum RW. Do salivary organic components play a protective role in health and disease of the esophageal mucosa? Digestion 1995:56(suppl 10):32 -37.
19. Richardson CT, Feldman M. Salivary response to food in humans and its effect on gastric acid secretion. Am .1 Physiol 1986;250:G85-91.
20. Sonnenberg A, Steinkamp U, Weise A, et al. Salivary secretion in reflux esophagitis. Gastroenterologe 1982:83:889-895.
21. Glass BJ. Drug-induced xerostomia as a cause of glossodynia. Ear Nose Throat J 1989:68:776-781.
22. Arrago JP, Rain JD, Brocheriou C, Rocher F. Scintigraphy of the salivary glands in Sjögreif s syndrome.J Clin Palhol 1987:40:1463-1467.
23. Yamashita T. Chiyonari I, Koichi T, Tadamt K. Prognostic determination and submamlibular function in Bell's palsy. Arch Otolatyngol 1985; 111:244-248.
24. Van den Akker HP. Buseman-Sokole E. Absolute indications for salivary gland scintigraphy with 'Tc-pertechnetate. Oral Surg Oral Med Oral Palhol 1985; 50: 440-447.
25. Helm JF. Role of saliva in esophageal function and disease. Dysphagia 1989:4:76- 34.
26. Dodds WJ. Hogen WJ, Helm JF, et al. Pathogenesis of reflux esophagitis. Gastro'titmilng\- 1981:81:376-394.
27. Helm JF. Dodds WJ. Hogen WJ, et al. Acid-neutralizing capacity of human saliva. Gastroenterologe 1982:83:69-74.
28. Rourk RM. Namiot Z. Sarosiek J. Yu Z, McCallum RW. Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chembal stimulation in patients with reflux esophagitis. Am J Gastroenterol 1994:89:237-244.
29. McCallum RW. Cisapride: a new class of prokinetic agent. Am J Gustroente'ol 1991:86:135-149.
30. Schurkes JAJ. Helsen LFM. Crghoos E, et al. Stimulation of gastroduodenal mo:or activity: dopaminergic and cholinergic modulation. Drug Dev Res 1986:8:233-24 .
31. Reynolds JC. Putnam PF. Prokinetic agents. Gastroenterol Clin North Am 1992;21: 567-569.
32. Inauen W. Emde C. Weber B, et al. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24-hour ambulatory combined pH and manomctry study. Gut 1993:34:1025-1031.
33. Wallin L. Kruse-Andersen S, Madsen T, Boesby S. Effect of cisapride on the gastro-ocsophageal function in normal human subjects. Digestion 1987;37:I60-165.
34. Ccccatelli P. Jansscns J. Vantrappen G, Cucchiara S. Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients. Gut 1988;i9: 631 635.
35. Gilbert RJ, Dodds WJ. Kahrilas PJ, Hogan WJ, Lipman S. Effect of cisapride. a new prokinetic agent, on esophageal motor function. Dig Dis Sei 1987:32:1331-1336.
36. Collins BJ. Spence RAJ, Ferguson R. Eaird J, Eove AHG. Cisapride. Influence 3n esophageal and gastric emptying time and gastroesophageal reflux in patients w th reflux esophagitis. Hepatogastroenterology 1987:34:113-116.
37. Horowitz M. Maddox A. Harding PE, et al. Effect of cisapride on gastric aid esophageal emptying in insulin-dependent diabetes mellitus. Gastroenterologe 1987: 92:1899- 1907.
38. William GP. Wang H. Beck IT. The effect of cisapride in patients with refl ix esophagitis: an ambulatory esophageal manometry/pH-metery study. Am J Gastmcnterol 1997:92:226-230.
39. Smout AJPM. Bogaard JW, Grodc AC, Ten Thije OJ, Akkermans LMA. Wittebol P. Effects of cisapride. a new gastrointestinal prokinetic substance, on interdigesti/e and postprandial motor activity of the distal oesophagus in man. Gut 1985:26:246-257.